Michael Look

Michael Look is a Senior Principal Scientist at Pfizer, where they serve as project lead in immune tolerance research and focus on identifying new drug targets. Previously, Michael was a Postdoctoral Associate at Yale School of Engineering & Applied Science, leading the development of tolerogenic vaccines, and a Research Engineer at the University of Washington, where they developed microfluidic assays for rapid disease diagnosis. In addition to their extensive research experience, Michael is pursuing an MBA at the University of Massachusetts Amherst and a PhD in Biomedical Engineering at Yale University, having also completed a Bachelor of Science in Bioengineering from the University of Washington.